SCHEMBL7521773

SCHEMBL7521773

CCn1cc(N)c(C(=O)NC)n1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.54
ALDH1A1 P00352 5/20 0.54
KDM4E B2RXH2 4/20 0.54
L3MBTL1 Q9Y468 2/20 0.41
HIF1A Q16665 1/20 0.41
EPAS1 Q99814 1/20 0.41
RAB9A P51151 9/20 0.40
SMN1; SMN2 Q16637 7/20 0.40
MAPK1 P28482 2/20 0.40
GAA P10253 1/20 0.40
HTT P42858 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PDE10A Q9Y233 1/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29282722 0.88 NPC1 (0.69) NPC1ALDH1A1KDM4EL3MBTL1RAB9A
SCHEMBL19885990 0.87 KDM4E (0.41) NPC1ALDH1A1KDM4EL3MBTL1HIF1A
SCHEMBL7510800 0.81 PDE10A (0.42) NPC1ALDH1A1KDM4ESMN1; SMN2HTT
SCHEMBL21961346 0.81 BACE1 (0.37) NPC1ALDH1A1KDM4ERAB9ASMN1; SMN2
SCHEMBL7517748 0.81 PDE10A (0.43) NPC1ALDH1A1KDM4ESMN1; SMN2PDE10A
SCHEMBL29419082 0.81 NPC1 (0.51) NPC1ALDH1A1KDM4EL3MBTL1HIF1A
SCHEMBL18077295 0.81 ALDH1A1 (0.50) NPC1ALDH1A1KDM4EL3MBTL1HIF1A
SCHEMBL28515221 0.81 NPC1 (0.50) NPC1ALDH1A1KDM4EL3MBTL1RAB9A
SCHEMBL7514149 0.80 PDE10A (0.45) NPC1ALDH1A1KDM4ESMN1; SMN2PDE10A
SCHEMBL3059091 0.80 ALDH1A1 (0.50) NPC1ALDH1A1KDM4EL3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP disclosed
CN-102947292-B nitrogen-containing heteroaryl compounds HOFFMAN-LA ROCHE LTD. (CH) 2015-08-19 CN disclosed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US disclosed
US-8623866-B2 2014-01-07 US disclosed
EP-2580207-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2013-04-17 EP disclosed
WO-2011154327-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 WO disclosed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS PDE10A, PDE3A, PDE2A NPC1 1285/4885ALDH1A1 271/4885KDM4E 2322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.